Florida Department of Transportation Purchases Cardiac Science Powerheart(R) AEDs for Safety Patrol Vehicle Fleet
26 Maio 2005 - 3:30AM
PR Newswire (US)
Florida Department of Transportation Purchases Cardiac Science
Powerheart(R) AEDs for Safety Patrol Vehicle Fleet Vehicles
Patrolling Florida's Turnpike Now Equipped With Life-Saving Devices
IRVINE, Calif., May 26 /PRNewswire-FirstCall/ -- Cardiac Science
Inc. (NASDAQ:DFIB), a leading manufacturer of live-saving automatic
public-access defibrillators (AEDs), announced today that Florida's
Turnpike Enterprise, a division of the Florida Department of
Transportation, has purchased Powerheart(R) AEDs for deployment in
the fleet of Safety Patrol trucks. The placement of the AEDs in the
Safety Patrol trucks follows recent deployments of Cardiac Science
AEDs in Florida's Turnpike service plazas and headquarters
facilities, said Richard Nelson, Director of Business Development
and Concessions Management for Florida's Turnpike Enterprise. The
AEDs were deployed in the Safety Patrol trucks this week and the
drivers have received comprehensive training in their use, Nelson
added. "These Powerheart AEDs are a valuable addition to the
vehicles in our Road Ranger program dedicated solely to patrolling
the Sawgrass Expressway and Florida's Turnpike mainline and helping
motorists in need," Nelson said. "We have worked alongside Cardiac
Science to deploy their AEDs, first in our facilities and now in
the Safety Patrol vehicles, as well as with the training of the
drivers. I feel certain these automatic defibrillators will prove
their value in the near future by saving lives either out on our
roadways or in our office buildings." Florida's Turnpike Road
Ranger program and the Safety Patrol trucks are sponsored by State
Farm. The trucks patrol the Sawgrass Expressway and Florida's
Turnpike's 309-mile mainline which extends from Dade City to I-75
in Sumter County, clear debris from the roadway and offer free
roadside assistance for stranded motorists A press conference
related to the AED deployment and other matters focused on the
safety along Florida's Turnpike system has been announced by
Florida Turnpike Enterprise and will be held at 11 a.m. Thursday,
May 26 (today) at the Turkey Lake Service Plaza in Orlando. About
Cardiac Science Cardiac Science develops, manufactures and markets
a complete line of Powerheart(R) brand, automatic public access
defibrillators (AEDs), and offers comprehensive AED/CPR training
and AED program management services that facilitate successful
deployments. The company makes the Powerheart(R) CRM(TM), the only
FDA-cleared therapeutic patient monitor that instantly and
automatically treats hospitalized cardiac patients who suffer
life-threatening heart rhythms. Cardiac Science also manufactures
its AED products on a private label basis for other leading medical
companies such as Nihon Kohden (Japan), Quinton Cardiology Systems
and GE Healthcare. For more information please visit
http://www.cardiacscience.com/ or call 1.949.797.3800. This press
release includes forward-looking statements. These statements may
be identified by the use of forward-looking terminology such as
"anticipate," "believe," "continue," "could," "estimate," "expect,"
"intend," "may," "might," "plan," "potential," "predict," "should,"
or "will," or the negative thereof or other variations thereon or
comparable terminology. Cardiac Science has based these
forward-looking statements on the current expectations,
assumptions, estimates and projections. While Cardiac Science
believes the Florida Turnpike Enterprise deployment to be a benefit
to the citizens of the region and will save lives, these
expectations, assumptions, estimates and projections, while
reasonable, are forward-looking statements and are only predictions
and involve known and unknown risks and uncertainties, many of
which are beyond our control. Certain factors, including those
discussed in Cardiac Sciences' Annual Report on Form 10-K for the
year ended December 31, 2004, under the heading "Risk Factors," may
cause the actual results, performance or achievements to differ
materially from any future results, performance or achievements
expressed or implied by these forward-looking statements. Given
these risks and uncertainties, you are cautioned not to place undue
reliance on such forward-looking statements. We do not undertake
any obligation to update any such statements or to publicly
announce the results of any revisions to any such statements to
reflect future events or developments. Contact: Matt Clawson
(Investors) Michael D. Gioffredi Len Hall (Media) Chief Marketing
Officer Allen & Caron Inc Cardiac Science, Inc. (949) 474-4300
(949) 797-3800 DATASOURCE: Cardiac Science Inc. CONTACT: Investors,
Matt Clawson, , or Media, Len Hall, , both of Allen & Caron
Inc, +1-949-474-4300, for Cardiac Science Inc.; or Michael D.
Gioffredi, Chief Marketing Officer of Cardiac Science, Inc.,
+1-949-797-3800, Web site: http://www.cardiacscience.com/
Copyright
Cardiac Science (NASDAQ:DFIB)
Gráfico Histórico do Ativo
De Set 2024 até Out 2024
Cardiac Science (NASDAQ:DFIB)
Gráfico Histórico do Ativo
De Out 2023 até Out 2024